SIB resources supporting SARS-CoV-2 research

SIB experts and resources are taking part in the global effort to develop dedicated data services, analysis tools and improve knowledge sharing to fight the COVID-19 pandemic.

Protein Spotlight: Now also a monthly comic strip

Discover the role tiny entities such as proteins play in the grand scheme of things – from smells to diseases – through an inspired dialogue between a biologist and a non-specialist.

ENYO Pharma SA and SIB make human protein interaction data publicly available

The SIB CALIPHO Group and ENYO Pharma SA worked hand-in-hand in a transnational public-private partnership (PPP) to make human protein interaction data publicly available and FAIR, through the SIB Resource neXtProt.

Addex and SIB receive Innosuisse grant to repurpose potent dopamine antagonist

Addex Therapeutics and SIB have been awarded a CHF600K Innosuisse grant to apply computational approaches developed by SIB to identify new therapeutic indications for a potent and selective dopamine D1 receptor antagonist.

Latest Protein Spotlight: Spotting patterns

Read how the ZBP1 protein comes into action when cells are undergoing stress in a viral infection for example, but is also associated with the onset and progression of certain cancers, as well as several autoimmune diseases.

How SIB is securing sensitive data for health-related research

As part of its infrastructure activities, SIB is in charge of BioMedIT, a secure and cutting-edge IT network across Switzerland, designed to support biomedical research and clinical bioinformatics.

July publications

Take a tour of SIB members' latest peer-reviewed articles and conference proceedings.

New development in the cancer diagnostics platform used at the HUG

In its latest version, the cancer diagnostics platform developed jointly by the Geneva University Hospitals (HUG) and SIB offers key additional molecular insights.